Try our mobile app

General information

MD Medical Group Investments PLC is a private healthcare provider in Russia. The Company specializes in women's and children's healthcare.
  • Good financial results growth rate 13.6% (average between last period year over year growth for revenue and EBITDA), there is acceleration compared to average historical growth rates (9.7%)
  • Dividend yield for the last twelve months 6.3%
  • Free cash flow yield 11.7% (LTM)
  • Share price is 195.4% higher than minimum and 15.3% lower than maximum for the last 3 years
  • The company is overvalued by EV / LTM EBITDA multiple compared to target level (6.7x vs
    )
  • Fundamental value created in LTM (estimate)
  • Taking into account the impact of the key rate 20.0% on the change in financial parameters: EBITDA adjustment is 463 mln rub as NetDebt * (current key rate - normalized 7%) / 2, expected EBITDA adjusted for key rate increases is 11 629 mln rub, expected mult is 5.9x, target mult is 5.1x, potential is -13.3%

Key Financials (Download financials)

Ticker: MDMG
Share price, RUB:  (+0.8%)1013.3
year average price 921.95  


year start price 831.60 2024-06-28

min close price 799.00 2024-07-05

max close price 1130.00 2025-03-21

current price 1011.50 2025-06-27
Common stocks: 75 130 000
Dividend Yield:  6.3%
FCF Yield LTM: 11.7%
EV / LTM EBITDA:6.7x
EV / EBITDA annualized: 6.4x
Last revenue growth (y/y):  17.5%
Last growth of EBITDA (y/y):  9.8%
Historical revenue growth:  9.8%
Historical growth of EBITDA:  9.5%
Target EV / EBITDA (hist percentile):
Express share price potential:
Fundamental value created in LTM:
Fundamental value created in LTM:
 Mult Upside-20.5%
 FCF Creation+11.7%
 Growth+13.6%
 Growth Corr+2.0%
 
 Sum+6.8%
EV / LTM EBITDA mutiple calculation
Market Cap (m RUB): 76 129
Net Debt (m RUB): -4 448
EV (Enterprise Value): 71 681
EBITDA LTM (m RUB): 10 681
Net Income LTM (m RUB): -4
EV / LTM EBITDA: 6.7x
Net Debt / LTM EBITDA (if EBITDA > 0): -0.4x
Average daily trading volume for the week, RUB mln: 50
P / B 2.5x
EBITDA margin ann-d 32.4%
Net income margin ann-d 0.0%

Revenue and EBITDA

Semi-Annual values (m RUB)

Change (y/y)

Cash Flow

FCF (m RUB), before FX effects elimination

Net Debt / Cash and Equivalents (m RUB)

Share price and dividends (Download history)

Share price

Payment RUB per share

Multiple and potential

EV / LTM EBITDA and 50% percentile

Potential dynamics

Daily trade volumes

Millions of RUB

P/B and P/E multipliers

P / B

P / E

More information for subscribed users:
detailed calculation of
Potential and Created Value,
commodities affecting the company